Overview
Lipoid pneumonitis encompasses conditions caused by lipid accumulation in lung tissue, including exogenous lipoid pneumonia (ELP) from aspiration or inhalation of oils and potentially other lipid-containing substances, and less commonly, complications related to necrobiosis lipida (NL), a granulomatous skin disease often associated with diabetes mellitus 13.Diagnosis
Clinical Presentation: Variable, ranging from respiratory symptoms to radiological infiltrates in ELP 2.
Imaging: Chest X-rays may show pulmonary infiltrates; CT scans can reveal characteristic alveolar changes 23.
Pathological Confirmation: Bronchoalveolar lavage (BAL) with cytological staining for extracellular lipids, or lung biopsy showing lipid-laden macrophages 23.
Differential Diagnosis: Exclude other causes of pulmonary infiltrates, including infections and other forms of aspiration pneumonia 2.
Biopsy: Recommended in clinically ambiguous cases or when malignancy is suspected 1.Management
Supportive Therapy: Oxygen therapy, mechanical ventilation as needed for respiratory failure 23.
Corticosteroids: Used to reduce inflammation in severe cases 2.
Stop Oil/Substance Exposure: Immediate cessation of exposure to lipid-containing substances 2.
Therapeutic Lung Lavage: Considered in refractory cases 2.
Surgical Resection: Reserved for localized, severe disease unresponsive to medical therapy 2.
Specific Treatment for Underlying Cause: Address any underlying conditions like organophosphate poisoning 3.Special Populations
Pediatrics: ELP can occur due to cultural practices involving oil ingestion or inhalation; preventive interventions are crucial 2.
Comorbidities: Patients with diabetes mellitus are at higher risk for necrobiosis lipida, which may complicate respiratory conditions if there is systemic involvement 1.Key Recommendations
Perform BAL or lung biopsy with lipid staining for definitive diagnosis of ELP (Evidence: Moderate) 2.
Initiate supportive respiratory care and consider corticosteroids for severe inflammation in ELP (Evidence: Moderate) 2.
Cease exposure to lipid-containing substances immediately upon suspicion of ELP (Evidence: Expert opinion) 2.
In cases of necrobiosis lipida with respiratory symptoms, consider systemic involvement and multidisciplinary management (Evidence: Expert opinion) 1.
For pediatric patients, implement preventive measures against ELP due to cultural practices (Evidence: Moderate) 2.References
1 Erfurt-Berge C, Renner R, Peckruhn M, Tittelbach J, Terhorst-Molawi D, Kauer F et al.. S1-Guideline for diagnosis and therapy of necrobiosis lipoidica. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026. link
2 Marangu D, Gray D, Vanker A, Zampoli M. Exogenous lipoid pneumonia in children: A systematic review. Paediatric respiratory reviews 2020. link
3 Nogué S, Sanz P, Borondo JC, Picón M, de la Red G, Mestre G. Fatal lipoid pneumonia due to bronco-aspiration of isoparaffin after ingestion of an organophosphate insecticide. Acta anaesthesiologica Scandinavica 2003. link
4 Vion B, Burri G, Ramelet AA. Necrobiosis lipoidica and silicotic granulomas on Muller's phlebectomy scars. Dermatology (Basel, Switzerland) 1997. link